JNJ vs MDT
By Alex · Tickerpine
Johnson & Johnson vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $254.66 | $80.98 |
| Market cap | $613.02B | $103.66B |
| P/E ratio | 29.5 | 21.7 |
| ROE | 26.42% | 9.84% |
| Profit margin | 21.83% | 13.20% |
| Revenue growth | 9.90% | 9.90% |
| Dividend yield | 2.10% | 3.56% |
| Beta | 0.26 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MDT in plain English
- JNJ is the bigger company — about 5.9× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.7 vs 29.5).
- JNJ earns a higher return on equity (26% vs 10%).
- MDT is growing revenue faster (10% vs 10%).
- MDT has the higher dividend yield (3.56% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.